摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,10-二羟基-2,2-二甲基-12-(3-甲基丁-2-烯基)吡喃并[5,6-b]氧杂蒽-6-酮 | 50816-23-4

中文名称
5,10-二羟基-2,2-二甲基-12-(3-甲基丁-2-烯基)吡喃并[5,6-b]氧杂蒽-6-酮
中文别名
5,10-二羟基-2,2-二甲基-12-(3-甲基丁-2-烯-1-基)-2H,6H-吡喃并[3,2-b]占吨-6-酮
英文名称
trapezifolixanthone
英文别名
toxyloxanthone A;Trapezifolixanthon;5,10-dihydroxy-2,2-dimethyl-12-(3-methylbut-2-enyl)pyrano[3,2-b]xanthen-6-one
5,10-二羟基-2,2-二甲基-12-(3-甲基丁-2-烯基)吡喃并[5,6-b]氧杂蒽-6-酮化学式
CAS
50816-23-4
化学式
C23H22O5
mdl
——
分子量
378.425
InChiKey
YWHROXVOOAEFOY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    28
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    76
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • Xanthone-rich plant extracts or compounds therefrom for modulating diseases of the central nervous system and related disorders
    申请人:Deakin University
    公开号:US10568862B2
    公开(公告)日:2020-02-25
    The invention relates to a method of treatment and/or prophylaxis of a disease or disorder of the central nervous system comprising administering to a mammal in need thereof an effective amount of a xanthone-rich plant extract, or a compound derived from a xanthone-rich plant extract. The invention also relates to use of a xanthone-rich plant extract, or a compound derived from a xanthone-rich plant extract, in the preparation of a medicament for the treatment and/or prophylaxis of a disease or disorder of the central nervous system and to a xanthone-rich plant extract, or a compound derived from a xanthone-rich plant extract, for use in the treatment and/or prophylaxis of a disease or disorder of the central nervous system.
    本发明涉及一种治疗和/或预防中枢神经系统疾病或紊乱的方法,包括向需要的哺乳动物施用有效量的富含黄酮的植物提取物或从富含黄酮的植物提取物衍生的化合物。 本发明还涉及富含黄酮的植物提取物或由富含黄酮的植物提取物衍生的化合物在制备治疗和/或预防中枢神经系统疾病或紊乱的药物中的用途,以及富含黄酮的植物提取物或由富含黄酮的植物提取物衍生的化合物在治疗和/或预防中枢神经系统疾病或紊乱中的用途。
  • XANTHONE-RICH PLANT EXTRACTS OR COMPOUNDS THEREFROM FOR MODULATING DISEASES OF THE CENTRAL NERVOUS SYSTEM AND RELATED DISORDERS
    申请人:DEAKIN UNIVERSITY
    公开号:EP3110414B1
    公开(公告)日:2020-09-30
  • [EN] XANTHONE-RICH PLANT EXTRACTS OR COMPOUNDS THEREFROM FOR MODULATING DISEASES OF THE CENTRAL NERVOUS SYSTEM AND RELATED DISORDERS<br/>[FR] EXTRAITS DE PLANTE RICHES EN XANTHONE OU COMPOSÉS DÉRIVÉS DE CEUX-CI POUR LA MODULATION DE MALADIES DU SYSTÈME NERVEUX CENTRAL ET DE TROUBLES ASSOCIÉS
    申请人:UNIV DEAKIN
    公开号:WO2015127512A1
    公开(公告)日:2015-09-03
    The invention relates to a method of treatment and/or prophylaxis of a disease or disorder of the central nervous system comprising administering to a mammal in need thereof an effective amount of a xanthone-rich plant extract, or a compound derived from a xanthone-rich plant extract. The invention also relates to use of a xanthone-rich plant extract, or a compound derived from a xanthone-rich plant extract, in the preparation of a medicament for the treatment and/or prophylaxis of a disease or disorder of the central nervous system and to a xanthone-rich plant extract, or a compound derived from a xanthone-rich plant extract, for use in the treatment and/or prophylaxis of a disease or disorder of the central nervous system.
查看更多